<DOC>
	<DOCNO>NCT01872858</DOCNO>
	<brief_summary>Patients vascular cognitive impairment-no dementia ( VCIND ) one group prescribe cilostazol , group prescribe aspirin . Evaluate cognitive function , MRI side give time . The investigator hypothesize cilostazol efficient safer aspirin patient VCIND .</brief_summary>
	<brief_title>Efficacy Safety Cilostazol Patients Vascular Cognitive Impairment-no Dementia ( VCIND )</brief_title>
	<detailed_description />
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Cilostazol</mesh_term>
	<criteria>1 . Aged 5080 , gender； 2 . Small vessel disease associate cognitive impairment , diagnose VCIND； 3 . Nonspecific subjective symptom ( dizziness , somnolence , numbness limb ) acceptable . 4 . Normal hepatic renal function . 5 . With good compliance . 1 . Aged 80 less 50 . 2 . Dementia . 3 . Cerebral infarction ( &gt; 2cm ) . 4 . Major vascular lesion . ( stenosis &gt; 50 % ) . 5 . Cardiac cerebral infarction . 6 . Intracerebral Hemorrhage . 7 . Clinical manifestation attribute small vessel disease . 8 . Major depression dysfunction speech , visual ability , hear aphasia would interfere cognitive assessment . 9 . Severe systematic organic impairment ( cardiac , hepatic , renal dysfunction ) . 10 . Thrombocytopenic Purpura . 11 . History hemorrhage digestive system surgery past 3 month . 12 . Previously cilostazol treatment 3 month . 13 . Allergic aspirin cilostazol . 14 . Enrolled clinical trial past 3 month . 15 . Lack informed consent compliance . 16 . Contraindications MRI scan .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>